Your browser doesn't support javascript.
loading
Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion.
Eissa, Shaimaa S; Clay, Michael R; Santiago, Teresa; Wu, Gang; Wang, Lu; Shulkin, Barry L; Picarsic, Jennifer; Nichols, Kim E; Campbell, Patrick K.
Afiliação
  • Eissa SS; Department of Pediatric Oncology, Children's Cancer Hospital-Egypt (57357), Cairo, Egypt.
  • Clay MR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Santiago T; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Wu G; Department of Pathology.
  • Wang L; Center for Applied Bioinformatics, and.
  • Shulkin BL; Department of Pathology.
  • Picarsic J; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN; and.
  • Nichols KE; Division of Pathology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Campbell PK; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Blood Adv ; 4(13): 2991-2995, 2020 07 14.
Article em En | MEDLINE | ID: mdl-32609843

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Xantogranuloma Juvenil / Receptor beta de Fator de Crescimento Derivado de Plaquetas Limite: Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Xantogranuloma Juvenil / Receptor beta de Fator de Crescimento Derivado de Plaquetas Limite: Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito